Evidence map›Paper›PMID 29509998›Full record

ArticlePlant biotechnology journal2018

Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathway.

Bo Min Kim, Hester Catharina Therese Lotter-Stark, Edward P Rybicki, Rachel K Chikwamba, Kenneth E Palmer

Open access · goldAbstract read
In one paragraph

Article in Plant biotechnology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Parallel, Continuous Monitoring and Quantification of Programmed Cell Death in Plant Tissue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Bo Min KimCenter for Predictive Medicine, James Graham Brown Cancer Center, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-9464-1145
Hester Catharina Therese Lotter-StarkBiosciences, Council for Scientific and Industrial Research (CSIR), Pretoria, South Africa.
Edward P RybickiDepartment of Molecular & Cell Biology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-8024-9911
Rachel K ChikwambaBiosciences, Council for Scientific and Industrial Research (CSIR), Pretoria, South Africa.
Kenneth E PalmerCenter for Predictive Medicine, James Graham Brown Cancer Center, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
Council for Scientific and Industrial Research · ZAUniversity of Louisville · USUniversity of Cape Town · ZA

Funding

Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entryU19AI113182 · NIAID · UNIVERSITY OF LOUISVILLE · PI FUQUA, JOSHUA L · 2014 to 2018
$14.8M
Antiviral lectins as microbicidesR01AI076169 · NIAID · UNIVERSITY OF LOUISVILLE · PI PALMER, KENNETH E · 2008 to 2011
$2.3M
Helmsley Charitable TrustNIAID NIH HHS R01 AI076169NIAID NIH HHS U19 AI113182
6 · The paper itself

Abstract

Griffithsin (GRFT) is an antiviral lectin, originally derived from a red alga, which is currently being investigated as a topical microbicide to prevent transmission of human immunodeficiency virus (HIV). Targeting GRFT to the apoplast for production in Nicotiana benthamiana resulted in necrotic symptoms associated with a hypersensitive response (HR)-like cell death, accompanied by H

Indexed as

Cell DeathNicotianaPlant LectinsPlants, Genetically ModifiedSalicylic AcidSecretory Pathwaygriffithsin protein, GriffithsiaPlant LectinsSalicylic Acidgriffithsin (GRFT)human immunodeficiency virus (HIV)hypersensitive response (HR)lectin

Identifiers

PMID29509998
PMCPMC6131415
OpenAlexW2791382803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.